Stay updated on IRX-2 Combo in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Combo in Gastric Cancer Clinical Trial page.

Latest updates to the IRX-2 Combo in Gastric Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content or functionality of the page.SummaryDifference0.1%
- Check22 days agoChange DetectedThe webpage has been updated to include detailed clinical staging information for various types of gastric and gastroesophageal junction cancers, as well as the addition of a new registry identifier and collaborators. Notably, significant content regarding the trial objectives and treatment protocols has been removed.SummaryDifference54%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to IRX-2 Combo in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Combo in Gastric Cancer Clinical Trial page.